These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27265029)

  • 1. Aberrant methylation of ATG2B, ATG4D, ATG9A and ATG9B CpG island promoter is associated with decreased mRNA expression in sporadic breast carcinoma.
    Zhang X; Li C; Wang D; Chen Q; Li CL; Li HJ
    Gene; 2016 Sep; 590(2):285-92. PubMed ID: 27265029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expressions and Clinical Significance of Autophagy-related Genes ATG2B, ATG4D, ATG9B in Breast Carcinoma].
    Zhang XM; Li HJ; Wang D; Li C; Chen Q; Li CL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Mar; 47(2):184-8. PubMed ID: 27263291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation may be an important mechanism of the transcriptional inactivation of ARRDC3, GATA5, and ELP3 in invasive ductal breast carcinoma.
    Wang D; Yang PN; Chen J; Zhou XY; Liu QJ; Li HJ; Li CL
    Mol Cell Biochem; 2014 Nov; 396(1-2):67-77. PubMed ID: 25148870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter CpG island hypermethylation during breast cancer progression.
    Park SY; Kwon HJ; Lee HE; Ryu HS; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
    Virchows Arch; 2011 Jan; 458(1):73-84. PubMed ID: 21120523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG methylation of APC promoter 1A in sporadic and familial breast cancer patients.
    Debouki-Joudi S; Trifa F; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Cancer Biomark; 2017; 18(2):133-141. PubMed ID: 27983523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
    Tang B; Jiang J
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
    Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG
    Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered methylation of glucosylceramide synthase promoter regulates its expression and associates with acquired multidrug resistance in invasive ductal breast cancer.
    Liu J; Zhang X; Liu A; Zhang D; Su Y; Liu Y; You D; Yuan L; Kong X; Wang X; Sun P
    Oncotarget; 2016 Jun; 7(24):36755-36766. PubMed ID: 27191984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.
    Muggerud AA; Rønneberg JA; Wärnberg F; Botling J; Busato F; Jovanovic J; Solvang H; Bukholm I; Børresen-Dale AL; Kristensen VN; Sørlie T; Tost J
    Breast Cancer Res; 2010; 12(1):R3. PubMed ID: 20056007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Datta Gupta S; Pandya P; Ralhan R
    Clin Biochem; 2010 Mar; 43(4-5):373-9. PubMed ID: 19879256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between CpG methylation profiles and hormone receptor status in breast cancers.
    Feng W; Shen L; Wen S; Rosen DG; Jelinek J; Hu X; Huan S; Huang M; Liu J; Sahin AA; Hunt KK; Bast RC; Shen Y; Issa JP; Yu Y
    Breast Cancer Res; 2007; 9(4):R57. PubMed ID: 17764565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer.
    Fu DY; Wang ZM; Wang BL; Chen L; Yang WT; Shen ZZ; Huang W; Shao ZM
    Hum Pathol; 2010 Jan; 41(1):48-58. PubMed ID: 19733895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors.
    Li Z; Chen B; Wu Y; Jin F; Xia Y; Liu X
    BMC Cancer; 2010 Mar; 10():98. PubMed ID: 20230646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma.
    Kang JH; Kim SJ; Noh DY; Park IA; Choe KJ; Yoo OJ; Kang HS
    Lab Invest; 2001 Apr; 81(4):573-9. PubMed ID: 11304577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
    Moelans CB; Verschuur-Maes AH; van Diest PJ
    J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methylation status and protein expression of adenomatous polyposis coli (APC) gene in breast cancer].
    Liu Z; Yang L; Cui DX; Liu BL; Zhang XB; Ma WF; Zhang Q
    Ai Zheng; 2007 Jun; 26(6):586-90. PubMed ID: 17562262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.